Protagonist Therapeutics, Inc. (PTGX)
94.27
+2.19
(+2.38%)
USD |
NASDAQ |
Mar 02, 16:00
94.27
0.00 (0.00%)
After-Hours: 16:30
Protagonist Therapeutics EPS Diluted (Quarterly) : -0.6932 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| ADMA Biologics, Inc. | 0.2025 |
| Glaukos Corp. | -2.324 |
| Krystal Biotech, Inc. | 1.699 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.38M |
| Revenue (Quarterly) | 7.437M |
| Total Expenses (Quarterly) | 51.82M |
| Enterprise Value | 5.199B |
| Gross Profit Margin (Quarterly) | 94.94% |
| Profit Margin (Quarterly) | -596.8% |
| Earnings Yield | -2.17% |
| Normalized Earnings Yield | -2.167 |